1.0000
+0.0306
+(3.16%)
As of 3:25:14 PM EDT. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 2 | 1 |
| Avg. Estimate | -0.13 | -0.13 | -1.16 | -0.52 |
| Low Estimate | -0.13 | -0.13 | -1.84 | -0.52 |
| High Estimate | -0.13 | -0.13 | -0.48 | -0.52 |
| Year Ago EPS | -- | -- | -3.05 | -1.16 |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 3 | 2 |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | -- | -- | 0.00% | 0.00% |
Earnings History
| Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | -1.05 | -0.85 | -1.78 | -0.38 |
| EPS Actual | -0.78 | -0.75 | -0.35 | -1.17 |
| Difference | 0.27 | 0.1 | 1.43 | -0.79 |
| Surprise % | 26.07% | 11.42% | 80.34% | -207.89% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.13 | -0.13 | -1.16 | -0.52 |
| 7 Days Ago | 0 | 0 | -1.16 | -0.52 |
| 30 Days Ago | 0 | 0 | -0.48 | -0.52 |
| 60 Days Ago | 0 | 0 | -0.48 | -0.52 |
| 90 Days Ago | 0 | 0 | -0.48 | -0.52 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | 1 | 1 |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| ARTL | -- | -- | 61.97% | 55.17% |
| S&P 500 | 6.76% | 5.73% | 9.19% | 14.14% |
Upgrades & Downgrades
| Maintains | D. Boral Capital: Buy to Buy | 4/2/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 3/4/2025 |
| Maintains | D. Boral Capital: Buy to Buy | 3/3/2025 |
| Maintains | D. Boral Capital: Buy to Buy | 2/27/2025 |
| Maintains | D. Boral Capital: Buy to Buy | 1/14/2025 |
| Maintains | D. Boral Capital: Buy to Buy | 12/9/2024 |
Related Tickers
THRD Third Harmonic Bio, Inc.
5.14
+0.88%
KTTA Pasithea Therapeutics Corp.
1.3520
+14.58%
ZVSA ZyVersa Therapeutics, Inc.
0.7900
-7.06%
CDT Conduit Pharmaceuticals Inc.
0.9038
+4.08%
HEPA Hepion Pharmaceuticals, Inc.
0.3559
-7.53%
THTX Theratechnologies Inc.
2.7650
+7.59%
ELAB PMGC Holdings Inc.
2.9802
-6.28%
PHIO Phio Pharmaceuticals Corp.
2.5731
+16.98%
CANF Can-Fite BioPharma Ltd.
1.2800
-1.54%
SXTP 60 Degrees Pharmaceuticals, Inc.
3.3900
+3.99%